Radiosensitising effect of mesenchymal stem cells on sarcoma M-1 under local gamma-irradiation
Автор: Sevankaeva L.E., Yuzhakov V.V., Konoplyannikov A.G., Romanko Yu.S., Bandurko L.N., Fomina N.K., Ingel I.E., Konoplyannikov M.A., Yakovleva N.D., Tsyganova M.G.
Рубрика: Научные статьи
Статья в выпуске: 3 т.26, 2017 года.
Бесплатный доступ
Very little information about effects of mesenchymal stem cells on malignant neoplasms radiosensitivity is available. The research aims to study impact of human mesenchymal stem cells (hMSC) on survival of tumor-bearing animals, tumor growth rate and morphology following single local irradiation of sarcoma M-1 by 60Co g-rays with dose of 30 Gy. Immunostaining technique for PCNA, CD31, pimonidazole and computer-assisted analysis of microscopic images are used to detect the effects. The results demonstrate activation of angiogenesis in tumor growth zones, increase in concentration of proliferating tumor cells in the neoplasm parenchyma, twofold reduction of hypoxic cells fraction following hMSCs transplantation. Quantitative analysis of impact of transplanted mesenchymal stem cells and local irradiation of the tumor identifies more pronounced radiation inactivation of tumor cells. In post-radiation period the growth rate of irradiated tumor cells reduces by 1.8 times, and cumulative survival fraction of tumor-bearing rats increases by 31%, as compared with the gamma-irradiated stem cells free animals with M-1 sarcoma. The results of research provide opportunity to identify and document radiosensitizing effect of hMSC administered prior to local irradiation of transplantable connective tissue tumor for the first time. There are reasons to suppose that increased radiosensitivity of sarcoma M-1 is caused by reduction of the most radioresistant hypoxic cells fraction in the irradiated area.
Mesenchymal stem cells, g-излучение, g-radiation, м-1 sarcoma, hypoxia, angiogenesis, immunohistochemistry, pcna, cd31, radiosensitization, pimonidazole
Короткий адрес: https://sciup.org/170170300
IDR: 170170300 | DOI: 10.21870/0131-3878-2017-26-3-100-115